2008 News
-
Press Release
Santen Announces Financial Result for the Second Quarter ended September 30, 2008
-
Press Release
Santen Announces Approval of TAPROS™ for Glaucoma and Ocular Hypertension Treatment in Japan
-
Press Release
-
Press Release
Santen Announces Financial Result for the First Quarter ended June 30, 2008
-
Press Release
Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)
-
Press Release
Notice on the Allotment of Stock Options (Stock Acquisition Rights)
-
Press Release
-
Press Release
-
Press Release
-
Press Release
Santen to Issue Stock Acquisition Rights to the Directors for the Purpose of Granting Stock Options
-
Press Release
-
Press Release
Notice on Board of Directors, Corporate Auditors and Corporate Officers
-
Press Release
Santen Announces Financial Results for the Year ended March 31, 2008
-
Press Release
-
Press Release
Notice Regarding the Completion of Purchase of the Company's Own Shares in the Market
-
Press Release
Notice Regarding the Purchase of the Company's Own Shares in the Market
-
Press Release
Santen to Lift Condition for Approval of PAPILOCK Mini Ophthalmic Solution 0.1%
-
Press Release
-
Press Release
Santen Announces Financial Result for the Third Quarter ended December 31, 2007 Appendix
-
Press Release